Overall, the upregulation of MIR222 could not only inhibit the expression of tumor suppressors such as target genes DIRAS3 and DCTN6 in prostate cancer but also prove that obesity has a strong correlation with cancer metastasis. Here, MIR222 is linked to obesity due to melanocortin 4 receptor deficiency.